Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Lyphar Biotech is a specialized manufacturer and global supplier focused on the research, development, and production of plant extracts, nutritional supplements, and pharmaceutical intermediates. Based in China, the company provides a diverse portfolio of high-purity ingredients, including nootropics, cosmetic raw materials, and active pharmaceutical ingredients (APIs). Their business model centers on large-scale manufacturing and export, serving the pharmaceutical, nutraceutical, and personal care industries worldwide. Lyphar Biotech operates production facilities that emphasize quality control and adherence to international standards to support global health and wellness applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Lyphar Biotech.